BioPacific Investors
BioPacific Investors is...
An angel investment group created to leverage cross-pacific business opportunities
by investing in early stage life science and healthcare companies with an Asia connection
Purpose
- Provide a funding source to emerging life science and healthcare companies that have a business focus on China/Asia and are pre-venture capital or do not fit traditional funding models
- Identify and present well-vetted cross-border investment opportunities to the membership
- Simplify the investment vehicle for members, companies and follow-on investors
- Contribute business, scientific and regional expertise to companies to improve probability for success
Organization
- Founded and managed by angel investors and life science executives with broad cross-pacific experience
- Non-profit member organization (501(c)6) with investments made through a for-profit LLC
- Operations funded by sponsors including Dorsey & Whitney, ChinaBio and others, and membership dues
- No override or management fees; all of investors’ funds go to the companies
- All work performed by members on a pro bono basis except Managing Director
Membership
- 60+ members in US, China, Japan, Korea, India, Singapore & Australia; offices in Palo Alto & Shanghai
- Individual members must be accredited investors with business or scientific expertise in life sciences
- Affiliate members include VC/PE firms and multinational corporations with a focus on life science
- Members must be recommended by two existing members and be accepted by Membership Committee
- Minimum investment requirement of $25,000/year; $2,000/year individual membership fee
Investment Opportunities
- Broad life science focus: pharma/biotech, medtech, diagnostics, digital health & healthcare services
- Robust deal flow of 350+ deals/yr from founders, members, sponsors, venture capitalists and universities
- Screening Committee reviews all investment opportunities and selects those to present to membership
- Five member investment meetings/year with ~two presenting companies (30 min. each)
- No charge to submit business plans or present to membership (if selected)
- Targeted investment range of $250,000 to $1 million per investment; potential to syndicate larger deals
- Companies must have or plan to have a presence in China or elsewhere in Asia
Contact Information
For membership or sponsorship information: BioPacific Investors, Inc.
Ann Gaddy, Managing Director Palo Alto, San Diego, Shanghai
.jpg){kind=logo}
ChinaBio Group is a sponsor of BioPacific Investors, but has no legal or financial interest and does not benefit from investments made by any other party.